Home > Insider Trading > Filing (0001661181-19-000015)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1661181	Organogenesis Holdings Inc.	ORGO	Biological Products, (No Disgnostic Substances) (2836)	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1074084	Albert Erani	C/O A&Amp;E Stores, Inc. 1000 Huyler Street Teterboro NJ 07608	Yes	No	Yes	No
1757286	A. Alan Ades	C/O A&Amp;E Stores, Inc. 1000 Huyler Street Teterboro NJ 07608	Yes	No	Yes	No
1757452	Gn 2016 Organo 10-Year Grat U/A/D September 30, 2016	35 Sawgrass Drive Bellport NY 11713	No	No	Yes	No
1757453	Gn 2016 Family Trust U/A/D August 12, 2016	35 Sawgrass Drive Bellport NY 11713	No	No	Yes	No
1757455	12/20/12 Dated Trust Issue 2012 Erani Dennis	C/O A&Amp;E Stores, Inc. 1000 Huyler Street Teterboro NJ 07608	No	No	Yes	No
1757567	Grat 2014 Ades Alan	C/O A&Amp;E Stores, Inc. 1000 Huyler Street Teterboro NJ 07608	No	No	Yes	No
1757573	Organo Investors Llc	C/O A&Amp;E Stores, Inc. 1000 Huyler Street Teterboro NJ 07608	No	No	Yes	No
1757580	Organo Pfg Llc	C/O A&Amp;E Stores, Inc. 1000 Huyler Street Teterboro NJ 07608	No	No	Yes	No
1760663	12/29/2012 Dated Trust Family Erani Albert	C/O A&Amp;E Stores, Inc. 1000 Huyler Street Teterboro NJ 07608	No	No	Yes	No
1760685	Dennis Erani	C/O A&Amp;E Stores, Inc. 1000 Huyler Street Teterboro NJ 07608	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2019-09-06	10,000	$5.03	67,961,823	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The reported securities were purchased and are held directly by Alan A. Ades, who is a member of the Group (as defined below).
The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $4.70 to $5.15, inclusive. The reporting person undertakes to provide to Organogenesis Holdings Inc. ("ORGO"), any security holder of ORGO, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.